Because BPC-157s mechanism of action already heavily involves NO system modulation, delivering L-arginine alongside the peptide may provide additional NOS substrate at the site of activity
The therapeutic window is 1025mg/mL for most research peptides, including 5-Amino-1MQ
What Makes Healthletic BPC-157 Worth Investigating While numerous companies are venturing into the oral peptide market, Healthletic BPC-157 distinguishes itself as a clean, lab-tested, orally available peptide supplement that eliminates the need for injections or complex protocols
Ozdemir R, Yurttutan S, Sar FN, Uysal B, Unverdi HG, Canpolat FE, et al
Such knowledge could inform the design of precision therapies that restore mitochondrial homeostasis in a tissue-specific manner while minimizing systemic side effects